Novo Nordisk: The Possible Upside [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
While the expected financial weakness is a real downer, there's a possibility of a sales surprise this year considering the company's recent vigorous actions as well as promising launches. NVO's forward P/E has fallen so low now that further upside looks unmistakable. This is especially true as the company is expected to return to improved financial health from 2027. Looking for a portfolio of ideas like this one? Members of Green Growth Giants get exclusive access to our subscriber-only portfolios. Learn More » Victor Golmer/iStock Editorial via Getty Images My last article in November 2025 on the obesity treatments' provider Novo Nordisk A/S's ( NVO ) was titled “ Consider The Counterfactual .” The title followed a sharp fall in its stock price More on my IG service This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (CPSE:NOVO B) Valuation After A Challenging Year For Shareholders [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk's New Diabetes Drug Outshines Ozempic: Is The Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Analysis-US could take action including fines against Hims after brief Wegovy copy launch [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novo Nordisk plans Wegovy vials amid obesity-drug competition [Yahoo! Finance]Yahoo! Finance
- West Pharma forecasts 2026 profit above estimates on strong demand for drug components [Yahoo! Finance Canada]Yahoo! Finance Canada
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/17/26 - Form 6-K
- 2/11/26 - Form 6-K
- 2/10/26 - Form 6-K
- NVO's page on the SEC website